Point72 Hong Kong LTD Bridge Bio Pharma, Inc. Transaction History

Point72 Hong Kong LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $311,462 - $484,845	39,227 New	39,227 $390,000
Q2 2022 Aug 15, 2022	SELL	$5.21 - $12.14 $30,895 - $71,990	-5,930 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $65,450 - $153,015	-8,917 Reduced 60.06%	5,930 $60,000
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $168,958 - $792,978	14,847 New	14,847 $248,000
Q4 2020 Feb 16, 2021	SELL	$38.38 - $71.11 $21,991 - $40,746	-573 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$27.2 - $42.19 $15,585 - $24,174	573 New	573 $21,000
Q3 2019 Nov 14, 2019	SELL	$20.13 - $32.38 $189,966 - $305,570	-9,437 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$26.97 - $27.55 $254,515 - $259,989	9,437 New	9,437 $255,000

315

177M

11.2M

2.29M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $5.17B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.